Integrated Filing — IndAS



General information about company

Scrip Code 540975
NSE Symbol ASTERDM
MSEI Symbol NOTLISTED
ISIN INE914M01019
Name of company Aster DM Quality Care Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 06-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 28-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 06-11-2026   01:35:00
End date and time of board meeting 06-11-2026   15:56:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 2,82,920.00 4,13,988.00
Other income 5,153.00 8,856.00
Total income 2,88,073.00 4,22,844.00
2 Expenses
(a) Cost of materials consumed 0.00 0.00
(b) Purchases of stock-in-trade 61,033.00 91,070.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 241.00 (619.00)
(d) Employee benefit expense 46,565.00 70,785.00
(e) Finance costs 11,898.00 15,019.00
(f) Depreciation, depletion and amortisation expense 14,966.00 21,895.00
(f) Other Expenses
1 Professional fees to consultant doctors 62,236.00 91,750.00
2 Laboratory outsourcing charges 1,900.00 2,822.00
3 Other expenses 44,604.00 65,407.00
4 0 0.00 0.00
5 0 0.00 0.00
6 0 0.00 0.00
7 0 0.00 0.00
8 0 0.00 0.00
9 0 0.00 0.00
10 0 0.00 0.00
Total other expenses 1,08,740.00 1,59,979.00
Total expenses 2,43,443.00 3,58,129.00
3 Total profit before exceptional items and tax 44,630.00 64,715.00
4 Exceptional items (1,895.00) (13,333.00)
5 Total profit before tax 42,735.00 51,382.00
6 Tax expense
7 Current tax 10,654.00 16,352.00
8 Deferred tax (957.00) (1,775.00)
9 Total tax expenses 9,697.00 14,577.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 33,038.00 36,805.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method (800.00) (1,639.00)
16 Total profit (loss) for period 32,238.00 35,166.00
17 Other comprehensive income net of taxes 978.00 988.00
18 Total Comprehensive Income for the period 33,216.00 36,154.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 26,202.00 27,808.00
Total profit or loss, attributable to non-controlling interests 6,036.00 7,358.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 27,044.00 28,660.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 6,172.00 7,494.00
21 Details of equity share capital
Paid-up equity share capital 87,168.00 87,168.00
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 3.19 4.14
Diluted earnings (loss) per share from continuing operations 3.19 4.13
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 3.19 4.14
Diluted earnings (loss) per share from continuing and discontinued operations 3.19 4.13
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 6,70,790.00
Capital work-in-progress 52,914.00
Investment property 1,534.00
Goodwill 2,72,110.00
Other intangible assets 97,854.00
Intangible assets under development 436.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 31,991.00
Non-current financial assets
Non-current investments 1,822.00
Trade receivables, non-current 0.00
Loans, non-current 297.00
Other non-current financial assets
1 Other financial assets 24,221.00
2 0 0.00
3 0 0.00
4 0 0.00
5 0 0.00
Total of other non-current financial assets 24,221.00
Total non-current financial assets 26,340.00
Deferred tax assets (net) 13,717.00
Other non-current assets
1 Income tax assets 23,098.00
2 Other non-current assets 21,641.00
3 Right-of-use assets 1,77,807.00
4 0 0.00
5 0 0.00
Total of other non-current assets 2,22,546.00
Total non-current assets 13,90,232.00
2 Current assets
Inventories 21,759.00
Current financial asset
Current investments 8,379.00
Trade receivables, current 84,139.00
Cash and cash equivalents 77,615.00
Bank balance other than cash and cash equivalents 1,38,001.00
Loans, current 0.00
Other current financial assets
Total of other current financial assets 21,392.00
Total current financial assets 3,29,526.00
Current tax assets (net) 0.00
Other current assets
1 Other current assets 10,762.00
2 0 0.00
3 0 0.00
4 0 0.00
5 0 0.00
Total of other current assets 10,762.00
Total current assets 3,62,047.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 17,52,279.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 87,168.00
Other equity 6,91,873.00
Total equity attributable to owners of parent 7,79,041.00
Non controlling interest 1,43,908.00
Total equity 9,22,949.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 3,41,016.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Lease liabilities 1,92,752.00
2 Other financial liabilities 5,073.00
3 0 0.00
4 0 0.00
5 0 0.00
Total of other non-current financial liabilities 1,97,825.00
Total non-current financial liabilities 5,38,841.00
Provisions, non-current 14,062.00
Deferred tax liabilities (net) 56,806.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
1 Other non-current liabilities 6,464.00
2 0 0.00
3 0 0.00
4 0 0.00
5 0 0.00
Total of other non-current liabilities 6,464.00
Total non-current liabilities 6,16,173.00
Current liabilities
Current financial liabilities
Borrowings, current 54,886.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 8,795.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1,03,447.00
Total Trade payable 1,12,242.00
Other current financial liabilities
1 Lease liabilities 5,385.00
2 Other financial liabilities 18,676.00
3 0 0.00
4 0 0.00
5 0 0.00
Total of other current financial liabilities 24,061.00
Total current financial liabilities 1,91,189.00
Other current liabilities 13,499.00
1 Other current liabilities 13,499.00
2 0 0.00
3 0 0.00
4 0 0.00
5 0 0.00
Total of other current liabilities 13,499.00
Provisions, current 2,727.00
Current tax liabilities (Net) 5,742.00
Deferred government grants, Current 0.00
Total current liabilities 2,13,157.00
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 8,29,330.00
Total equity and liabilites 17,52,279.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Hospitals & Clinics 2,77,284.00 4,05,047.00
2 Others 11,291.00 18,636.00
3 0 0.00 0.00
4 0 0.00 0.00
5 0 0.00 0.00
6 0 0.00 0.00
7 0 0.00 0.00
8 0 0.00 0.00
9 0 0.00 0.00
10 0 0.00 0.00
11 0 0.00 0.00
12 0 0.00 0.00
13 0 0.00 0.00
14 0 0.00 0.00
15 0 0.00 0.00
Total Segment Revenue 2,88,575.00 4,23,683.00
Less: Inter segment revenue 5,655.00 9,695.00
Revenue from operations 2,82,920.00 4,13,988.00
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Hospitals & Clinics 54,464.00 78,356.00
2 Others 1,301.00 1,584.00
3 0 0.00 0.00
4 0 0.00 0.00
5 0 0.00 0.00
6 0 0.00 0.00
7 0 0.00 0.00
8 0 0.00 0.00
9 0 0.00 0.00
10 0 0.00 0.00
11 0 0.00 0.00
12 0 0.00 0.00
13 0 0.00 0.00
14 0 0.00 0.00
15 0 0.00 0.00
Total Profit before tax 55,765.00 79,940.00
i. Finance cost 11,898.00 15,019.00
ii. Other Unallocable Expenditure net off Unallocable income 1,932.00 15,178.00
Profit before tax 41,935.00 49,743.00
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Hospitals & Clinics 16,31,536.00 16,31,536.00
2 Others 45,345.00 45,345.00
3 0 0.00 0.00
4 0 0.00 0.00
5 0 0.00 0.00
6 0 0.00 0.00
7 0 0.00 0.00
8 0 0.00 0.00
9 0 0.00 0.00
10 0 0.00 0.00
11 0 0.00 0.00
12 0 0.00 0.00
13 0 0.00 0.00
14 0 0.00 0.00
15 0 0.00 0.00
Total Segment Asset 16,76,881.00 16,76,881.00
Un-allocable Assets 75,398.00 75,398.00
Net Segment Asset 17,52,279.00 17,52,279.00
4 Segment Liabilities
Segment Liabilities
1 Hospitals & Clinics 8,05,104.00 8,05,104.00
2 Others 8,676.00 8,676.00
3 0 0.00 0.00
4 0 0.00 0.00
5 0 0.00 0.00
6 0 0.00 0.00
7 0 0.00 0.00
8 0 0.00 0.00
9 0 0.00 0.00
10 0 0.00 0.00
11 0 0.00 0.00
12 0 0.00 0.00
13 0 0.00 0.00
14 0 0.00 0.00
15 0 0.00 0.00
Total Segment Liabilities 8,13,780.00 8,13,780.00
Un-allocable Liabilities 15,550.00 15,550.00
Net Segment Liabilities 8,29,330.00 8,29,330.00
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of net defined benefit liability (794.00) (794.00)
Total Amount of items that will not be reclassified to profit and loss (794.00) (794.00)
2 Income tax relating to items that will not be reclassified to profit or loss (222.00) (222.00)
3 Amount of items that will be reclassified to profit and loss
1 Exchange difference in translating financial statements of foreign operations 1,550.00 1,564.00
Total Amount of items that will be reclassified to profit and loss 1,550.00 1,564.00
4 Income tax relating to items that will be reclassified to profit or loss 0.00 4.00
5 Total Other comprehensive income 978.00 988.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 51,382.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 15,019.00
Adjustments for decrease (increase) in inventories (523.00)
Adjustments for decrease (increase) in trade receivables, current (11,872.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current (4,348.00)
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 0.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 21,895.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 11,776.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 1,424.00
Adjustments for interest income 5,760.00
Adjustments for share-based payments 385.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (74.00)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 3,682.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 28,756.00
Net cash flows from (used in) operations 80,138.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 17,012.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 63,126.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 2,906.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 182.00
Purchase of property, plant and equipment 43,228.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 505.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 1,424.00
Interest received 7,991.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 1,12,730.00
Net cash flows from (used in) investing activities 75,688.00
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 55,939.00
Proceeds from issuing shares 410.00
Proceeds from issuing other equity instruments 1,934.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 13,186.00
Repayments of borrowings 12,171.00
Payments of lease liabilities 7,888.00
Dividends paid 15,780.00
Interest paid 8,028.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (84,276.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 54,538.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 270.00
Net increase (decrease) in cash and cash equivalents 54,808.00
Cash and cash equivalents cash flow statement at beginning of period 22,807.00
Cash and cash equivalents cash flow statement at end of period 77,615.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M/S Deloitte Haskins & Sells Yes 30-04-2028